Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria Novisedlakova"'
Autor:
Maria Urbanova, Verona Buocikova, Lenka Trnkova, Sabina Strapcova, Viera Horvathova Kajabova, Emma Barreto Melian, Maria Novisedlakova, Miroslav Tomas, Peter Dubovan, Julie Earl, Jozef Bizik, Eliska Svastova, Sona Ciernikova, Bozena Smolkova
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 4, p 2117 (2022)
Due to abundant stroma and extracellular matrix, accompanied by lack of vascularization, pancreatic ductal adenocarcinoma (PDAC) is characterized by severe hypoxia. Epigenetic regulation is likely one of the mechanisms driving hypoxia-induced epithel
Externí odkaz:
https://doaj.org/article/e3b00744b0f14efcb916cefe3c9bfda6
Publikováno v:
Biomedicines, Vol 8, Iss 12, p 565 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignant tumors due to the absence of biomarkers for early-stage detection and poor response to therapy. Since mounting evidence supports the role of microbiota composition in tum
Externí odkaz:
https://doaj.org/article/2caee98e9f3e43ee8d6f2a7bbea303e9
Autor:
Martin KUKUCKA, Ludovit DANIHEL, Milan ORAVSKY, Matus RAJCOK, Michal BERNADIC, Paula KOVAROVA, Natalie BIRKNEROVA,Marian CERNY, Maria NOVISEDLAKOVA, Miriam DRAHOKOUPILOVA, Milan SCHNORRER
Publikováno v:
Bratislava Medical Journal.
Publikováno v:
Biomedicines
Biomedicines, Vol 8, Iss 565, p 565 (2020)
Biomedicines, Vol 8, Iss 565, p 565 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignant tumors due to the absence of biomarkers for early-stage detection and poor response to therapy. Since mounting evidence supports the role of microbiota composition in tum
Autor:
Michal Mego, Radoslav Danis, Jozef Chovanec, Silvia Jurisova, Branislav Bystricky, Stefan Porsok, Peter Konkolovsky, Vladimir Vaclav, Maria Wagnerova, Marian Streško, Bibiana Brezinova, Mária Rečková, Dagmar Sutekova, Natalia Pazderova, Mária Novisedlakova, Eva Zomborska, Sona Ciernikova, Daniela Svetlovska, Lubos Drgona
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe incidence of irinotecan-induced diarrhea varies between 60-90%, by which the incidence of severe diarrhea is 20-40%. The objective of this phase III trial was to determine the effectiveness of the probiotic mixture containing Bifidobact
Externí odkaz:
https://doaj.org/article/90f3d7448e0b418f9c9713fc6d2328e5